BG106394A - A medicament and method for the production thereof - Google Patents

A medicament and method for the production thereof

Info

Publication number
BG106394A
BG106394A BG106394A BG10639402A BG106394A BG 106394 A BG106394 A BG 106394A BG 106394 A BG106394 A BG 106394A BG 10639402 A BG10639402 A BG 10639402A BG 106394 A BG106394 A BG 106394A
Authority
BG
Bulgaria
Prior art keywords
dihydrophthalazine
medicament
dione
amino
produced
Prior art date
Application number
BG106394A
Other languages
Bulgarian (bg)
English (en)
Inventor
Musa ABIDOV
Alexandr KHOKHLOV
Original Assignee
Musa ABIDOV
RAMAZANOV Ziadin
PAVLOV Anatoly
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26654045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG106394(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2000107351A external-priority patent/RU2155043C1/ru
Priority claimed from RU2000120270A external-priority patent/RU2163122C1/ru
Application filed by Musa ABIDOV, RAMAZANOV Ziadin, PAVLOV Anatoly filed Critical Musa ABIDOV
Publication of BG106394A publication Critical patent/BG106394A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BG106394A 2000-03-28 2002-02-06 A medicament and method for the production thereof BG106394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2000107351A RU2155043C1 (ru) 2000-03-28 2000-03-28 Способ получения лекарственного препарата
RU2000120270A RU2163122C1 (ru) 2000-08-01 2000-08-01 Лекарственное средство
PCT/RU2001/000086 WO2001072305A1 (fr) 2000-03-28 2001-02-28 Composition médicamenteuse et procédé de fabrication correspondant

Publications (1)

Publication Number Publication Date
BG106394A true BG106394A (en) 2002-12-29

Family

ID=26654045

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106394A BG106394A (en) 2000-03-28 2002-02-06 A medicament and method for the production thereof

Country Status (9)

Country Link
US (1) US6489326B1 (xx)
EP (1) EP1203587B1 (xx)
AT (1) ATE473743T1 (xx)
AU (1) AU4291201A (xx)
BG (1) BG106394A (xx)
CZ (1) CZ2002235A3 (xx)
DE (1) DE60142541D1 (xx)
EA (1) EA004056B1 (xx)
WO (1) WO2001072305A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2167659C1 (ru) * 2000-08-02 2001-05-27 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ коррекции иммунной системы живого организма
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
WO2005012309A1 (en) * 2003-08-04 2005-02-10 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
BRPI0307864B1 (pt) * 2003-11-25 2016-01-12 Univ Rio De Janeiro processo para formação de hidrazidas a partir de hidrazinas e ácido dicarboxílicos
PL231885B1 (pl) 2009-01-16 2019-04-30 Abidopharma Spolka Z Ograniczona Odpowiedzialnoscia Sposób wytwarzania soli 5-amino-2,3-dihydroftalazyno-1,4-di onu z metalami alkalicznymi, ich kompozycje farmaceutyczne i ich zastosowanie
EP2393361B1 (en) * 2009-02-06 2016-12-07 Bach Pharma, Inc. Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
AU2011223226B2 (en) * 2010-03-01 2015-04-23 Metriopharm Ag Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
ES2753577T3 (es) 2014-12-18 2020-04-13 Metriopharm Ag Forma cristalina de 5-amino-2,3-dihidroftalazina-1,4-diona sal sódica, los preparados farmacéuticos que la contengan y método de producción
RU2625267C1 (ru) * 2016-09-22 2017-07-12 Общество с ограниченной ответственностью "АБИДАФАРМА" Способ производства нестерильных субстанций безводного "тамерита" и/или двухводного "галавита" - натриевых солей 5-амино-2,3-дигидрофталазин-1,4-диона (варианты) и способы дальнейшей их переработки в стерильные лекарственные препараты
US20210379063A1 (en) * 2018-10-26 2021-12-09 Immunopharma Plus D.O.O. Oral aminodihydrophthalazinedione compositions and their use in the treatment of non-viral hepatitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU130903A1 (ru) * 1959-11-21 1959-11-30 Е.П. Крысин Способ получени 5-амино-2,3-дигидрофталазиндиона-1,4 (люминола)
GB1480591A (en) * 1973-10-31 1977-07-20 Boots Co Ltd Substituted phthalazines and their use as therapeutic agents
US4226993A (en) * 1978-07-24 1980-10-07 Miles Laboratories, Inc. Amino-functionalized phthalhydrazides
CH683965A5 (it) 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
CH683966A5 (it) 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.
RU2113222C1 (ru) * 1997-09-30 1998-06-20 Закрытое акционерное общество "Центр современной медицины "Медикор" Иммуномодулирующее средство
RU2138264C1 (ru) 1999-05-06 1999-09-27 Абидов Муса Тажудинович Способ получения лекарственного препарата галавит
RU2155043C1 (ru) * 2000-03-28 2000-08-27 Абидов Муса Тажудинович Способ получения лекарственного препарата
RU2167659C1 (ru) * 2000-08-02 2001-05-27 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ коррекции иммунной системы живого организма

Also Published As

Publication number Publication date
EA004056B1 (ru) 2003-12-25
US20020198208A1 (en) 2002-12-26
EP1203587A1 (en) 2002-05-08
ATE473743T1 (de) 2010-07-15
AU4291201A (en) 2001-10-08
EA200101261A1 (ru) 2002-06-27
DE60142541D1 (de) 2010-08-26
EP1203587B1 (en) 2010-07-14
CZ2002235A3 (cs) 2002-05-15
EP1203587A4 (en) 2006-11-08
WO2001072305A1 (fr) 2001-10-04
US6489326B1 (en) 2002-12-03

Similar Documents

Publication Publication Date Title
YU84703A (sh) Oralni rastvor aripiprazola
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
AU2002360949A1 (en) 17Alpha-ALKYL-17Beta-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17Alpha-ALKYL-17Beta-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS
HUP0400200A3 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
ZA95631B (en) Prolineamide derivatives
NZ514574A (en) Novel method of treatment
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
GB9914486D0 (en) Medicaments
BG106394A (en) A medicament and method for the production thereof
YU69902A (sh) Novi derivati piperazina
AU2323897A (en) Cyclopropyl alkanoic acid derivatives
AU2002227931A1 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds
IL160075A0 (en) Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
AU2364600A (en) Heteroroaromatic amides as inhibitor of factor xa
HUP0203437A3 (en) Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases
WO2004026306A3 (en) Pyrazole derivatives as transforming growth factor (tgf) inhibitors
IL148288A0 (en) Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
MY125428A (en) ?-carboline drug products
YU94103A (sh) Novi derivati sulfonske kiseline
CA2412047A1 (en) Shortened synthesis of 3,3-diarylpropylamine derivatives
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
IL150528A0 (en) Ibuprofen containing active agent preparation
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.